These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23873765)
61. The bacterial injection kit: type III secretion systems. Mota LJ; Cornelis GR Ann Med; 2005; 37(4):234-49. PubMed ID: 16019722 [TBL] [Abstract][Full Text] [Related]
62. Identification of chlamydial T3SS inhibitors through virtual screening against T3SS ATPase. Grishin AV; Luyksaar SI; Kapotina LN; Kirsanov DD; Zayakin ES; Karyagina AS; Zigangirova NA Chem Biol Drug Des; 2018 Mar; 91(3):717-727. PubMed ID: 29068165 [TBL] [Abstract][Full Text] [Related]
63. The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence. Jorgensen I; Bednar MM; Amin V; Davis BK; Ting JP; McCafferty DG; Valdivia RH Cell Host Microbe; 2011 Jul; 10(1):21-32. PubMed ID: 21767809 [TBL] [Abstract][Full Text] [Related]
64. Type III secretion system in Chlamydia species: identified members and candidates. Subtil A; Blocker A; Dautry-Varsat A Microbes Infect; 2000 Apr; 2(4):367-9. PubMed ID: 10817638 [TBL] [Abstract][Full Text] [Related]
65. High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway. Ernst NH; Reeves AZ; Ramseyer JE; Lesser CF mBio; 2018 Jun; 9(3):. PubMed ID: 29921672 [TBL] [Abstract][Full Text] [Related]
66. Fluorescence-Reported Allelic Exchange Mutagenesis-Mediated Gene Deletion Indicates a Requirement for Chlamydia trachomatis Tarp during Ghosh S; Ruelke EA; Ferrell JC; Bodero MD; Fields KA; Jewett TJ Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32152196 [TBL] [Abstract][Full Text] [Related]
67. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Dahlgren MK; Zetterström CE; Gylfe S; Linusson A; Elofsson M Bioorg Med Chem; 2010 Apr; 18(7):2686-703. PubMed ID: 20219378 [TBL] [Abstract][Full Text] [Related]
68. A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia. Davis AJ; Díaz DA; Mecsas J Mol Microbiol; 2010 Apr; 76(1):236-59. PubMed ID: 20199604 [TBL] [Abstract][Full Text] [Related]
69. The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells. Ho TD; Starnbach MN Infect Immun; 2005 Feb; 73(2):905-11. PubMed ID: 15664932 [TBL] [Abstract][Full Text] [Related]
70. Identification of novel Xanthomonas euvesicatoria type III effector proteins by a machine-learning approach. Teper D; Burstein D; Salomon D; Gershovitz M; Pupko T; Sessa G Mol Plant Pathol; 2016 Apr; 17(3):398-411. PubMed ID: 26104875 [TBL] [Abstract][Full Text] [Related]
71. HpaC controls substrate specificity of the Xanthomonas type III secretion system. Lorenz C; Schulz S; Wolsch T; Rossier O; Bonas U; Büttner D PLoS Pathog; 2008 Jun; 4(6):e1000094. PubMed ID: 18584024 [TBL] [Abstract][Full Text] [Related]
72. Genome and proteome analysis of Chlamydia. Vandahl BB; Birkelund S; Christiansen G Proteomics; 2004 Oct; 4(10):2831-42. PubMed ID: 15378744 [TBL] [Abstract][Full Text] [Related]
73. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967 [TBL] [Abstract][Full Text] [Related]
74. A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane. Olson MG; Ouellette SP; Rucks EA J Proteomics; 2020 Feb; 212():103595. PubMed ID: 31760040 [TBL] [Abstract][Full Text] [Related]
75. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G mBio; 2018 Jan; 9(1):. PubMed ID: 29382731 [No Abstract] [Full Text] [Related]
76. Chlamydia pneumoniae effector chlamydial outer protein N sequesters fructose bisphosphate aldolase A, providing a benefit to bacterial growth. Ishida K; Matsuo J; Yamamoto Y; Yamaguchi H BMC Microbiol; 2014 Dec; 14():330. PubMed ID: 25528659 [TBL] [Abstract][Full Text] [Related]
77. Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells. Bridge DR; Martin KH; Moore ER; Lee WM; Carroll JA; Rocha CL; Olson JC Infect Immun; 2012 Sep; 80(9):3049-64. PubMed ID: 22689823 [TBL] [Abstract][Full Text] [Related]
78. Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria. Büttner D Microbiol Mol Biol Rev; 2012 Jun; 76(2):262-310. PubMed ID: 22688814 [TBL] [Abstract][Full Text] [Related]
79. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis. Zhang Y; Romanov G; Bliska JB Infect Immun; 2011 Nov; 79(11):4322-31. PubMed ID: 21844228 [TBL] [Abstract][Full Text] [Related]
80. T3SEdb: data warehousing of virulence effectors secreted by the bacterial Type III Secretion System. Tay DM; Govindarajan KR; Khan AM; Ong TY; Samad HM; Soh WW; Tong M; Zhang F; Tan TW BMC Bioinformatics; 2010 Oct; 11 Suppl 7(Suppl 7):S4. PubMed ID: 21106126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]